The United States has the most confirmed COVID-19 cases in the world but currently falls behind most other countries in testing and detection abilities. While there have been new types of testing kits that have been introduced to the Magic Number® Patent Radian® the past couple of months, the majority of the patent documents from the Management - detect and monitor category of the Pandemics/Epidemics sector disclose detection of COVID-19 from biological samples (ex. US Patent No. 10,689,716) or test assays (ex. US Patent No. 10,541,056).
This past week, US Patent Application 20200214649 entailing an optimal COVID-19 detection method for emergencies using imaging systems was published. The application encompasses novel steps to detect COVID-19 by positioning a patient between a generator and a scintillator to obtain a diagnosis for the treatment of the patient with the light waves produced by the scintillator. Prior to the invention, there was no invention that allowed medical professionals to easily visualize COVID-19 aspects presently hidden to them. Fortunately, this invention allows detection at the earliest stage of infection where the individual is capable of spreading the disease asymptomatically.
Analyze the claims of this novel application and stay up to date with patent documents related to the pandemic with the free Magic Number® Pandemic Patent Forecast®.
